Sars-cov-2 mrna-1273 (6m-5y) vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with sars-cov-2 mrna-1273 (6m-5y) vaccine
V
- vamorolone
- Vanflyta (quizartinib)
- Vaqta (hepatitis a adult vaccine)
- Vaqta Pediatric (hepatitis a pediatric vaccine)
- varicella virus vaccine
- Varivax (varicella virus vaccine)
- Vaxchora (cholera vaccine, live)
- Vaxelis (diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid)
- Vaxneuvance (pneumococcal 15-valent conjugate vaccine)
- vedolizumab
- Velban (vinblastine)
- Velcade (bortezomib)
- Velsipity (etrasimod)
- Venclexta (venetoclax)
- venetoclax
- VePesid (etoposide)
- Veripred 20 (prednisolone)
- Versacloz (clozapine)
- Verzenio (abemaciclib)
- Vidaza (azacitidine)
- vinblastine
- Vincasar PFS (vincristine)
- vincristine
- vincristine liposome
- vinorelbine
- Vivimusta (bendamustine)
- Vivotif (typhoid vaccine, live)
- voclosporin
- Vonjo (pacritinib)
- Votrient (pazopanib)
- Vumerity (diroximel fumarate)
- Vumon (teniposide)
- Vyvgart (efgartigimod alfa)
- Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase)
- Vyxeos (cytarabine liposomal / daunorubicin liposomal)
More about sars-cov-2 mrna-1273 (6m-5y) vaccine
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.